All Stories

  1. “But that is your opinion”: the dark side of postmodern pain medicine creating a postmodern patient autonomy
  2. Phenytoin and carbamazepine in trigeminal neuralgia: marketing-based versus evidence-based treatment
  3. EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
  4. New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells
  5. The Role of Palmitoylethanolamide, an Autacoid, in the Symptomatic Treatment of Muscle Cramps: Three Case Reports and Review of Literature
  6. Natural compound palmitoylethanolamide helps in sciatic pain and carpal tunnel syndrome
  7. Increasing the Degrees of Freedom for Treating Painful Diabetic Neuropathy
  8. Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
  9. Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
  10. Palmitoylethanolamide and baclofen cream helps in vagina pain syndrome
  11. Pain Management
  12. Palmitoylethanolamide (PEA)—‘Promiscuous’ anti-inflammatory and analgesic molecule at the interface between nutrition and pharma
  13. Neuropathic Pain as a Result of Acromegaly, Treated With Topical Baclofen Cream
  14. Idiopathic neuropathy and pain can be treated with the supplement palmitoylethanolamide
  15. Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical
  16. Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
  17. Analgesics without side-effects and how to use palmitoylethanolamide and alpha-lipoic acid!
  18. Chemotherapy induced neuropathic pain treated with neuroprotectant palmitoylethanolamide
  19. Professor Rita Levi-Montalcini on Nerve Growth Factor, Mast Cells and Palmitoylethanolamide, an Endogenous Anti-Inflammatory and Analgesic Compound
  20. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold
  21. Palmitoylethanolamide: a supplement effective in chronic pain
  22. Intractable Neuropathic Pain in Spinal Intramedullary Cavernoma Treated Successfully with a Novel Combination Cream
  23. New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoylethanolamide
  24. Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%
  25. Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
  26. Effectiveness of the association micronized N-palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain
  27. Reply to “Letter to Editor” by Keppel Hesselink JM “Effectiveness of the association micronized N-palmitoylethanolamine (PEA)–transpolydatin in the treatment of chronic pelvic pain”
  28. High Doses of Topical Amitriptyline in Neuropathic Pain: Two Cases and Literature Review
  29. Topical Amitriptyline in Post-Traumatic Neuropathic Pain
  30. Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report
  31. Letter to the Editor
  32. An integrative medicine approach for the treatment of neuropathic pain
  33. A quality indicator for CAM interventions: The IOCOB traffic light grading system
  34. Nerve Regeneration in Neuropathic Pain
  35. A New Combination Cream for the Treatment of Severe Neuropathic Pain
  36. St John's Wort and its Active Principles in Dipression and Anxiety. W. E. Müller. Birkhausen Verlag: Basel, Switzerland. 2005. ISBN 3-7643-6160-3. Pages 188.
  37. Clinical Research on Acupuncture: Part 1. What Have Reviews of the Efficacy and Safety of Acupuncture Told Us So Far?
  38. Concise guide to the cytochrome P450 system. Drug interaction principles for medical practice. Kelly L. Cozza and Scott C. Armstrong. American Psychiatric Publishing, Washington DC, 2001. Pages: 272. ISBN: 1‐58562‐000‐9. Paperback. Price: £25.50
  39. Dance-drugs en cybercultuur
  40. De toekomstige medicamenteuze behandeling van de ziekte van Alzheimer: van symptomatische naar causale therapie
  41. Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants
  42. Evolution of concepts and definitions of Parkinson's disease since 1817*
  43. Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder
  44. The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention
  45. Ipsapirone in the treatment of bulimia nervosa: An open pilot study
  46. Behavioral pharmacology of serotonin receptor subtypes: hypotheses for clinical applications of selective serotonin ligands
  47. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder
  48. A Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Ipsapirone Versus Lorazepam in Patients With Generalized Anxiety Disorder
  49. Serotonin and Parkinson's Disease
  50. Depression in the course of treatment of generalized anxiety disorder with lorazepam, ipsapirone, and placebo: Results from a multicenter trial
  51. Letter to editor
  52. Reversible motor neuron disease
  53. Sertraline in the prevention of depression
  55. Nimodipine tested in a human model of cerebral ischaemia
  56. Letters to the editor